Patent · US Active

Compositions and methods for treating joints

US11090328B2 · kind B2 · utility

0Cited by

81References

21Claims

0Family size

Assignee

Medos International Sarl · CH

Inventors

Julia Hwang · Wayland, US
Dongling Su · Franklin, US
Julius Lopez · Milton, US

Key dates

Filing date	Jul 10, 2018
Grant date	Aug 17, 2021
Priority date	—
Expiry date	Jul 10, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods are provided for treating joint conditions, such as osteoarthritis and/or the pain associated therewith. The compositions and methods utilize a first component, namely hyaluronic acid (“HA”), in combination with a lyophilized second component that is effective to at least temporarily reduce the viscosity of the HA. In an exemplary embodiment, the second component is one or more glycosaminoglycans (“GAG”), such as chondroitin sulfate (“CS”), including CS4 and/or CS6, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. The composition can optionally include other joint supplements, such as glucosamine (“GlcN”).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.